Lock-Up Agreement May 18, 2020Merger Agreement • June 10th, 2020 • Revance Therapeutics, Inc. • Pharmaceutical preparations • Delaware
The undersigned (the “Stockholder”) understands that: (i) REVANCE THERAPEUTICS, INC., a Delaware corporation (“Parent”), has entered into an Agreement and Plan of Merger and Reorganization, dated as of May 18, 2020 (the “Merger Agreement”), with HINT, INC., a Delaware corporation (the “Company”) and HEART MERGER SUB, INC., a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”), pursuant to which Merger Sub will be merged with and into the Company (the “Merger”) and the separate corporate existence of Merger Sub will cease and the Company will continue as the surviving corporation; and (ii) in connection with the Merger, stockholders of the Company will receive shares of Parent Common Stock. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement.
LOAN AGREEMENTLoan Agreement • June 10th, 2020 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California
VOTING AGREEMENTVoting Agreement • June 10th, 2020 • Revance Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is entered into as of May 18, 2020, by and between REVANCE THERAPEUTICS, INC., a Delaware corporation (“Parent”), and [●] (“Stockholder”).
June 9, 2020 Revance Therapeutics, Inc.Reorganization Agreement • June 10th, 2020 • Revance Therapeutics, Inc. • Pharmaceutical preparations
